Weifang Shengtai Medicine Co.,Ltd

Weifang Shengtai Pharmaceutical Co.,LTD., which is a Wholly Foreign-Owned Enterprise that controlled by U.S. Shengtai Holding Inc., share listed-company of U.S.A. on May,2007. The company has a registered capital of $15,000,000 and total asset of $45,860,000. Its principal office, which occupies an area of 286,000 square meters with 806 staffs, is located in Changle Development Zone of Weifang, Shandong Province, China.



Weifang Shengtai Pharmaceutical Co.,LTD. is engaged in production and distribution of Glucose Monohydrate Injection Grade, Glucose Monohydrate Oral Grade, Glucose Anhydrous Injection Grade, Corn Starch, Dextrine, Sodium Gluconate and Avermectins series products. Our products have been passed approval of GMP, HACCP certificates, ISO9000 Quality System certificates and QS certificate. The products of the company have been exported to over 70 countries and areas. Glucose for injection, which is the company's core product, occupies over 60% market share in China, and the sales volume of glucose for injunction ranks No.1 domestically.